442 Fulvestrant (‘Faslodex’) demonstrates clinical benefit in heavily pre-treated patients with metastatic breast cancer
- 30 September 2003
- journal article
- abstracts
- Published by Elsevier in European Journal of Cancer Supplements
- Vol. 1 (5) , S135
- https://doi.org/10.1016/s1359-6349(03)90474-5
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: